Andrew Walsh - 09 May 2025 Form 3 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Vice President, Finance
Signature
/s/ Andrew Walsh
Issuer symbol
ANVS
Transactions as of
09 May 2025
Net transactions value
$0
Form type
3
Filing time
16 May 2025, 17:00:17 UTC
Next filing
18 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Walsh Andrew Vice President, Finance C/O ANNOVIS BIO, INC., 101 LINDENWOOD DR. SUITE 225, MALVERN /s/ Andrew Walsh 16 May 2025 0002068849

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ANVS Option (Right to Buy) 09 May 2025 Common Stock 10,000 $6.07 Direct F1
holding ANVS Option (Right to Buy) 09 May 2025 Common Stock 4,000 $6.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and is exercisable quarterly in equal installments over two years commencing on February 17, 2024, subject to continued service with the Company on the applicable vesting dates.
F2 The option vests and is exercisable quarterly in equal installments over two years commencing on March 6, 2025, subject to continued service with the Company on the applicable vesting dates.